000 01643 a2200445 4500
005 20250518000655.0
264 0 _c20190227
008 201902s 0 0 eng d
022 _a1950-6007
024 7 _a10.1016/j.biopha.2018.09.041
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKim, Miseon
245 0 0 _aSilencing Bmi1 expression suppresses cancer stemness and enhances chemosensitivity in endometrial cancer cells.
_h[electronic resource]
260 _bBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
_cDec 2018
300 _a584-589 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aApoptosis
_xgenetics
650 0 4 _aCadherins
_xgenetics
650 0 4 _aCaspase 3
_xgenetics
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Movement
_xgenetics
650 0 4 _aCell Survival
_xgenetics
650 0 4 _aEndometrial Neoplasms
_xgenetics
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIn Situ Nick-End Labeling
_xmethods
650 0 4 _aMitogen-Activated Protein Kinase 7
_xgenetics
650 0 4 _aOctamer Transcription Factor-3
_xgenetics
650 0 4 _aPoly(ADP-ribose) Polymerases
_xgenetics
650 0 4 _aRNA, Small Interfering
_xgenetics
650 0 4 _aSOXB1 Transcription Factors
_xgenetics
700 1 _aLee, Seul
700 1 _aPark, Wook Ha
700 1 _aSuh, Dong Hoon
700 1 _aKim, Kidong
700 1 _aKim, Yong Beom
700 1 _aNo, Jae Hong
773 0 _tBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
_gvol. 108
_gp. 584-589
856 4 0 _uhttps://doi.org/10.1016/j.biopha.2018.09.041
_zAvailable from publisher's website
999 _c28862747
_d28862747